The challenge of childhood diabetes mellitus in India

Insights

Childhood diabetes mellitus (DM) affects 0.4/1000 children, with specific genetic markers like HLA Bw21 and DR3 linked to Type 1 DM. Malnutrition-related DM in India presents differently, lacking these genetic associations.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Immunology

Background:

  • Diabetes Mellitus (DM) in children has a prevalence of approximately 0.4/1000, with children representing 3-5% of all diabetes cases.
  • A significant portion of pediatric DM cases do not present with ketoacidosis upon admission, and some have an early onset before age 4.

Purpose of the Study:

  • To investigate the immunological and genetic factors associated with childhood Type 1 Diabetes Mellitus (T1DM).
  • To describe the characteristics and potential etiologies of Malnutrition-Related Diabetes Mellitus (MRDM) in Indian adolescents.
  • To assess the mortality rates and contributing factors in pediatric DM patients.

Main Methods:

  • Analysis of HLA antigen and islet cell antibody (ICA) prevalence in childhood T1DM.
  • Serological testing for Coxsackie B2 virus antibodies.
  • Measurement of C-peptide levels.
  • Clinical and biochemical characterization of Malnutrition-Related Diabetes Mellitus (MRDM).

Main Results:

  • Childhood T1DM showed strong linkage disequilibrium with HLA antigens Bw21 (RR=12.7) and DR3 (RR=16.6).
  • Islet cell antibodies (ICA) were found in 30.9% of T1DM patients, and increased antibodies against Coxsackie B2 virus were observed (75.5%).
  • MRDM in Indian adolescents presented with moderate hyperglycemia, low serum glycerol, insulin insensitivity, and pancreatic abnormalities, without association with HLA or ICA; mortality was higher in resource-limited settings.

Conclusions:

  • Childhood T1DM has distinct genetic and immunological markers, including specific HLA types and autoantibodies.
  • Malnutrition-Related Diabetes Mellitus (MRDM) is a distinct entity in adolescents, with unclear etiology but significant clinical implications.
  • Effective management and healthcare access are crucial for reducing mortality in pediatric DM, especially in impoverished regions.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...